THERIVA BIOLOGICS INC TOVX
COM NEW · Common Stock · CUSIP 87164U508
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersRockville, MD
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 9.6m as of 2025-08-07, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $0.43.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2024 | 19 |
| Q4 2024 | 11 |
| Q1 2025 | 11 |
| Q2 2025 | 18 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2024 | 3 | 10 |
| Q1 2025 | 4 | 5 |
| Q2 2025 | 9 | 3 |
Biggest buyers
| CITADEL ADVISORS LLC | New | +36.0k |
| Virtu Financial LLC | New | +34.5k |
| TWO SIGMA SECURITIES, LLC | New | +17.8k |
| XTX Topco Ltd | New | +17.2k |
| FMR LLC | New | +3.0k |
| CLEAR STREET LLC | New | +100 |
| SBI Securities Co., Ltd. | Added | +50 |
| BANK OF AMERICA CORP /DE/ | Added | +33 |
| Pandora Wealth, Inc. | New | +4 |
Biggest sellers
| UBS Group AG | Reduced | -7.8k |
| OSAIC HOLDINGS, INC. | Reduced | -440 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -82 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Jeffrey Matthew Gryga Irrevocable Trust 13G · passive investor new · filed 2025-11-10 | 7.7% |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| Ikarian Capital, LLC 0.02% of their portfolio | 120.0k $52.1k | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 36.0k $15.6k | New |
| BOOTHBAY FUND MANAGEMENT, LLC 0.00% of their portfolio | 35.6k $15.4k | Unchanged |
| Virtu Financial LLC 0.00% of their portfolio | 34.5k $15.0k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 18.6k $8.1k | Reduced -82 |
| TWO SIGMA SECURITIES, LLC 0.00% of their portfolio | 17.8k $7.7k | New |
| XTX Topco Ltd 0.00% of their portfolio | 17.2k $7.5k | New |
| BlackRock, Inc. 0.00% of their portfolio | 7.6k $3.3k | Unchanged |
| FMR LLC 0.00% of their portfolio | 3.0k $1.3k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 444 $190 | Reduced -440 |
| CLEAR STREET LLC 0.00% of their portfolio | 100 $43 | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 74 $32 | Added +33 |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 60 $26 | Added +50 |
| IFP Advisors, Inc 0.00% of their portfolio | 11 $5 | Unchanged |
| Pandora Wealth, Inc. 0.00% of their portfolio | 4 $2 | New |
| DANSKE BANK A/S 0.00% of their portfolio | 1 $0 | Unchanged |
| UBS Group AG 0.00% of their portfolio | 1 $0 | Reduced -7.8k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |